IngMar Medical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • IngMar Medical's estimated annual revenue is currently $8M per year.(i)
  • IngMar Medical's estimated revenue per employee is $251,000

Employee Data

  • IngMar Medical has 32 Employees.(i)
  • IngMar Medical grew their employee count by -6% last year.

IngMar Medical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director EngineeringReveal Email/Phone
3
Director FinanceReveal Email/Phone
4
Director Product ManagementReveal Email/Phone
5
Director OperationsReveal Email/Phone
6
Clinical Education ManagerReveal Email/Phone
7
Human Resources ManagerReveal Email/Phone
8
Manager, Customer SuccessReveal Email/Phone
9
PresidentReveal Email/Phone
10
Senior Mechanical Design EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$73.5M29312%N/AN/A
#2
$7M28-10%N/AN/A
#3
$37.9M15113%N/AN/A
#4
$2.1M17-78%$64.3MN/A
#5
$9.3M37-10%N/AN/A
#6
$56.2M1790%N/AN/A
#7
$38.9M155-1%N/AN/A
#8
$22.1M885%N/AN/A
#9
$22.1M889%N/AN/A
#10
$33.4M13310%N/AN/A
Add Company

What Is IngMar Medical?

IngMar Medical's respiratory simulators and test lungs are used worldwide to provide hands-on clinician training, test ventilator performance, and accelerate research and development. Our ASL 5000 is the world’s most sophisticated breathing simulator – ”the gold standard” – and the only high fidelity neonatal breathing simulator available. Join the ASL 5000 Breathing Simulator User Forum, https://www.linkedin.com/groups/8157006. ISO 9001:2008 certification serves as a validation of our deep commitment to quality and customer satisfaction. Through our Internship Program we have employed more than 25 interns, primarily through a relationship with the RWTH-Aachen University in Germany.

keywords:N/A

N/A

Total Funding

32

Number of Employees

$8M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A3210%N/A
#2
N/A3210%N/A
#3
$6.9M323%N/A
#4
$5.4M323%N/A
#5
$6.9M3210%N/A